Have a feature idea you'd love to see implemented?
Let us know!
ENOV Enovis Corp
Price (delayed)
$46.67
Market cap
$2.61B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.18
Enterprise value
$3.97B
Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB
Highlights
The revenue has grown by 21% YoY and by 4.6% from the previous quarter
The gross profit has increased by 19% year-on-year and by 4% since the previous quarter
The net income has dropped by 59% year-on-year and by 32% since the previous quarter
ENOV's EPS has dropped by 58% year-on-year and by 32% since the previous quarter
Key stats
What are the main financial stats of ENOV
Market
Valuations
Earnings
Shares outstanding
55.88M
Market cap
$2.61B
Enterprise value
$3.97B
Price to book (P/B)
0.78
Price to sales (P/S)
1.3
EV/EBIT
N/A
EV/EBITDA
22.12
EV/Sales
1.98
Revenue
$2B
EBIT
-$87.73M
EBITDA
$179.28M
Free cash flow
-$71.88M
Per share
Balance sheet
Liquidity
EPS
-$2.18
Free cash flow per share
-$1.29
Book value per share
$59.63
Revenue per share
$35.84
TBVPS
$31.51
Total assets
$5.55B
Total liabilities
$2.22B
Debt
$1.39B
Equity
$3.33B
Working capital
$672.84M
Debt to equity
0.42
Current ratio
2.27
Quick ratio
0.82
Net debt/EBITDA
7.57
Margins
Efficiency
Dividend
EBITDA margin
9%
Gross margin
56.8%
Net margin
-6%
Operating margin
-5.8%
Return on assets
-2.3%
Return on equity
-3.6%
Return on invested capital
-3.9%
Return on capital employed
-1.7%
Return on sales
-4.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENOV stock price
How has the Enovis stock price performed over time
Intraday
1.08%
1 week
0.63%
1 month
16.53%
1 year
-8.08%
YTD
-16.69%
QTD
8.41%
Financial performance
How have Enovis's revenue and profit performed over time
Revenue
$2B
Gross profit
$1.14B
Operating income
-$116.73M
Net income
-$119.19M
Gross margin
56.8%
Net margin
-6%
The net income has dropped by 59% year-on-year and by 32% since the previous quarter
Enovis's net margin has decreased by 33% YoY and by 28% from the previous quarter
Enovis's operating income has decreased by 32% YoY and by 11% from the previous quarter
The revenue has grown by 21% YoY and by 4.6% from the previous quarter
Growth
What is Enovis's growth rate over time
Valuation
What is Enovis stock price valuation
P/E
N/A
P/B
0.78
P/S
1.3
EV/EBIT
N/A
EV/EBITDA
22.12
EV/Sales
1.98
ENOV's EPS has dropped by 58% year-on-year and by 32% since the previous quarter
ENOV's P/B is 22% below its 5-year quarterly average of 1.0 and 13% below its last 4 quarters average of 0.9
ENOV's equity is down by 3.2% YoY
ENOV's P/S is 57% below its 5-year quarterly average of 3.0 and 13% below its last 4 quarters average of 1.5
The revenue has grown by 21% YoY and by 4.6% from the previous quarter
Efficiency
How efficient is Enovis business performance
The ROIC has dropped by 144% year-on-year and by 22% since the previous quarter
The ROE has plunged by 64% YoY and by 33% from the previous quarter
ENOV's ROS is down by 38% since the previous quarter
Enovis's ROA has decreased by 35% YoY and by 28% from the previous quarter
Dividends
What is ENOV's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Enovis financials performed over time
The total assets is 150% more than the total liabilities
Enovis's total liabilities has surged by 131% YoY and by 3% QoQ
The total assets has increased by 26% YoY
Enovis's debt is 58% less than its equity
ENOV's equity is down by 3.2% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.